$81.5 Million is the total value of Texas Children's's 3 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 95.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSM | Buy | BLACK STONE MINERALS LP COM UNIT REPSTG LTD PARTNER INT | $72,694,000 | +81.7% | 4,689,939 | +106.7% | 89.21% | +83.3% |
| EPD | ENTERPRISE PRODS PARTNERS L P COM UNIT | $7,404,000 | -0.8% | 256,470 | 0.0% | 9.09% | +0.1% | |
| EPSN | New | EPSILON ENERGY LTD | $1,385,000 | – | 369,249 | +100.0% | 1.70% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC COM | $0 | – | -60,479 | -100.0% | -0.60% | – |
| AMRN | Exit | AMARIN CORP PLCsponsored adr new | $0 | – | -28,197 | -100.0% | -0.71% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC COM | $0 | – | -64,348 | -100.0% | -0.74% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC COM | $0 | – | -45,589 | -100.0% | -0.75% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC COM | $0 | – | -25,485 | -100.0% | -0.76% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC. | $0 | – | -24,471 | -100.0% | -0.80% | – |
| ZGNX | Exit | ZOGENIX INC COM NEW | $0 | – | -13,429 | -100.0% | -0.90% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC COM | $0 | – | -8,409 | -100.0% | -0.90% | – |
| SGEN | Exit | SEATTLE GENETICS INC COM | $0 | – | -10,566 | -100.0% | -0.94% | – |
| INCY | Exit | INCYTE CORP COM | $0 | – | -9,125 | -100.0% | -0.96% | – |
| CCXI | Exit | CHEMOCENTRYX INC COM | $0 | – | -58,142 | -100.0% | -0.98% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC COM | $0 | – | -9,202 | -100.0% | -0.99% | – |
| GHDX | Exit | GENOMIC HEALTH INC COM | $0 | – | -11,967 | -100.0% | -1.02% | – |
| ABMD | Exit | ABIOMED INC COM | $0 | – | -3,169 | -100.0% | -1.10% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC COM | $0 | – | -7,389 | -100.0% | -1.22% | – |
| BGNE | Exit | BEIGENE LTD SPONSORED ADRsponsored adr | $0 | – | -8,306 | -100.0% | -1.33% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL COM | $0 | – | -9,397 | -100.0% | -1.34% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD SHS | $0 | – | -30,546 | -100.0% | -1.44% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC COM | $0 | – | -140,733 | -100.0% | -1.58% | – |
| Exit | ASCENDIS PHARMA A/S SPONSORED ADRsponsored adr | $0 | – | -16,206 | -100.0% | -2.32% | – | |
| OIH | Exit | VANECK VECTORS ETF OIL SVCS ETFoil svc etf | $0 | – | -135,589 | -100.0% | -2.84% | – |
| XOP | Exit | SPDR SER TR S&P OIL & GAS EXPL & PRODTN ETFs&p oilgas exp | $0 | – | -482,603 | -100.0% | -18.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLACK STONE MINERALS LP COM UNIT REPSTG LTD PARTNER INT | 8 | Q3 2020 | 89.2% |
| ENTERPRISE PRODS PARTNERS L P COM UNIT | 8 | Q3 2020 | 21.7% |
| EPSILON ENERGY LTD | 5 | Q3 2020 | 5.7% |
| SPDR SER TR S&P OIL & GAS EXPL & PRODTN ETF | 2 | Q1 2019 | 18.0% |
| VANECK VECTORS ETF OIL SVCS ETF | 2 | Q1 2019 | 2.8% |
| ASCENDIS PHARMA A/S SPONSORED ADR | 2 | Q1 2019 | 2.3% |
| BEIGENE LTD SPONSORED ADR | 2 | Q1 2019 | 1.5% |
| ABIOMED INC COM | 2 | Q1 2019 | 1.7% |
| INCYTE CORP COM | 2 | Q1 2019 | 1.5% |
| ALEXION PHARMACEUTICALS INC COM | 2 | Q1 2019 | 1.2% |
View Texas Children's's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-13 |
| 13F-HR | 2019-05-14 |
| 13F-HR | 2019-02-14 |
View Texas Children's's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.